Irinotecan activation by human carboxylesterases in colorectal adenocarcinoma cells.
about
Carboxylesterase-2 is a highly sensitive target of the antiobesity agent orlistat with profound implications in the activation of anticancer prodrugs.A highly efficient tumor-infiltrating MDSC differentiation system for discovery of anti-neoplastic targets, which circumvents the need for tumor establishment in mice.A self-contained enzyme activating prodrug cytotherapy for preclinical melanoma.Ontogenic expression of human carboxylesterase-2 and cytochrome P450 3A4 in liver and duodenum: postnatal surge and organ-dependent regulation.Unfavourable expression of pharmacologic markers in mucinous colorectal cancer.A cell-delivered and cell-activated SN38-dextran prodrug increases survival in a murine disseminated pancreatic cancer modelHuman carboxylesterases HCE1 and HCE2: ontogenic expression, inter-individual variability and differential hydrolysis of oseltamivir, aspirin, deltamethrin and permethrin.Synthesis, characterization, and evaluation of mPEG-SN38 and mPEG-PLA-SN38 micelles for cancer therapy.Suppression of carboxylesterases by imatinib mediated by the down-regulation of pregnane X receptor.Regulation of carboxylesterase-2 expression by p53 family proteins and enhanced anti-cancer activities among 5-fluorouracil, irinotecan and doxazolidine prodrug.The feasibility of enzyme targeted activation for amino acid/dipeptide monoester prodrugs of floxuridine; cathepsin D as a potential targeted enzyme.In vitro and in vivo evaluation of SN-38 nanocrystals with different particle sizesA novel microfluidic liposomal formulation for the delivery of the SN-38 camptothecin: characterization and in vitro assessment of its cytotoxic effect on two tumor cell lines
P2860
Q33916086-A34A1998-4C9A-4631-A888-E93FF6E2279AQ34365909-03A54D4F-504A-4B0E-8A2B-25F72982EF02Q35569028-3ED38455-CE97-4EF6-AE9B-31A8A18A871EQ35833727-323C38E2-9EDA-42EE-8701-65C7B32DF8F0Q36616168-8239423B-3B38-4895-8AAA-B9032CE6D033Q36641472-F51398D9-0237-453C-9A9C-C522988F62DFQ37163881-966D0EFA-1DB2-430D-B28D-F8D7AE41A0BFQ38768937-EAD9F767-C5D4-44CD-95DA-86D552D85ABFQ38995804-A52B1E78-1A00-406E-953D-4AD9096958BCQ39200965-A93D8497-7C1E-4C18-83F0-4490E555E41BQ39373589-890D520A-785B-4454-A266-69B1C13FD053Q41283296-54FA37F5-9240-4D8F-B117-DC3CC33A7EECQ58750910-7FF5BCFD-9BE6-44F8-A765-50598E477A06
P2860
Irinotecan activation by human carboxylesterases in colorectal adenocarcinoma cells.
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Irinotecan activation by human carboxylesterases in colorectal adenocarcinoma cells.
@ast
Irinotecan activation by human carboxylesterases in colorectal adenocarcinoma cells.
@en
type
label
Irinotecan activation by human carboxylesterases in colorectal adenocarcinoma cells.
@ast
Irinotecan activation by human carboxylesterases in colorectal adenocarcinoma cells.
@en
prefLabel
Irinotecan activation by human carboxylesterases in colorectal adenocarcinoma cells.
@ast
Irinotecan activation by human carboxylesterases in colorectal adenocarcinoma cells.
@en
P2093
P1476
Irinotecan activation by human carboxylesterases in colorectal adenocarcinoma cells.
@en
P2093
Bingfang Yan
M Eileen Dolan
Michael H Wu
Rod Humerickhouse
P304
P407
P577
2002-08-01T00:00:00Z